Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SWX/CURN stock hub

SWX/CURN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/CURNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

119.1M

SIX Swiss Exchange

Market data

Price

Recent price action with selectable time range.

SWX/CURNSWX/CURN

—

Loading chart…

In the news

Latest news · SWX/CURN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E1.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3.1

P25 n/aP50 n/aP75 n/a

ROIC-2.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/CURN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

CHF

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	9
Enterprise value	CHF 117.2M
Exchange	SIX Swiss Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CH1330780979
Last refreshed	2026-05-10
Market cap	CHF 119.1M
Price	CHF 23.1
Price currency	CHF
Rev Per Employee	1,200,000x
Sector	Healthcare
Sic	2834
Symbol	swx/CURN
Website	https://curatis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.19%
EV Earnings	-82.76x
EV/Sales	10.85x
Forward P/E	1.38x
P/B ratio	2.58x
P/S ratio	11.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-14.31%
EBITDA Margin	-10.76%
Gross margin	26.31%
Gross Profit	CHF 2.8M
Gross Profit Growth	15.95%
Gross Profit Growth Q	33.74%
Gross Profit Growth3 Y	88.1%
Net Income	CHF -1.4M
Net Income Growth Years	2%
Pretax Margin	-14.13%
Profit Margin	-13.11%
Profit Per Employee	CHF -157,333
ROA	-1.73
ROCE	-2.93
ROE	-3.09
ROIC	-2.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	137.8%
EPS Growth Years	3
Revenue Growth	56.61x
Revenue Growth Q	13.02x
Revenue Growth Years	1x
Revenue Growth3 Y	76.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.19
Assets	CHF 56M
Cash	CHF 1.9M
Current Assets	CHF 5.5M
Current Liabilities	CHF 3.3M
Equity	CHF 46.1M
Interest Coverage	-96.56
Liabilities	CHF 9.9M
Long Term Assets	CHF 50.5M
Long Term Liabilities	CHF 6.6M
Net Cash	CHF 1.9M
Net Cash By Market Cap	CHF 1.57
Net Cash Growth	-38.06%
Net Debt Equity	CHF -0.04
Tangible Book Value	CHF -4.1M
Tangible Book Value Per Share	CHF -0.8
WACC	-0.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.65
Inventory Turnover	4.77
Net Working Capital	CHF 291,000
Quick ratio	1.03
Working Capital	CHF 2.2M
Working Capital Turnover	CHF 4.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-71.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	137.65%
200-day SMA	15.57
50-day SMA	22.32
50-day SMA vs 200-day SMA	50over200
All Time High	27.9
All Time High Change	-17.2%
All Time High Date	2026-03-11
All Time Low	5
All Time Low Change	362%
All Time Low Date	2024-08-22
ATR	1.03
Beta	-0.83
Beta1y	-0.35
Beta2y	-1.22
Ch YTD	92.5
High	23.5
High52	27.9
High52 Date	2026-03-11
High52ch	-17.2%
Low	22.8
Low52	9.76
Low52 Date	2025-05-19
Low52ch	137.65%
Ma50ch	3.51%
Price vs 200-day SMA	48.35%
RSI	48.44
RSI Monthly	64.03
RSI Weekly	65.93
Sharpe ratio	1.33x
Sortino ratio	2.86
Total Return	-71.41%
Tr YTD	92.5
Tr1m	5%
Tr1w	-4.15%
Tr3m	40.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF -1.5M
Operating margin	-14.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,804,049%
Shares Insiders	65%
Shares Institutions	0.01%
Shares Out	5,154,049
Shares Qo Q	1.3%
Shares Yo Y	71.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,767.7x
Bv Per Share	8.94
Ch1m	5
Ch1w	-4.15
Ch1y	137.7
Ch3m	40.43
Ch6m	84.06
Change	-1.7%
Change From Open	0
Close	23.5
Days Gap	-1.7
Depreciation Amortization	383,000
Dollar Volume	214,691.4
Earnings Date	2026-06-15
EBIT	CHF -1.5M
EBITDA	CHF -1.2M
EPS	CHF -0.28
F Score	4
Financing CF	1,382,000
Fiscal Year End	December
Founded	2,002
Income Tax	CHF -110,000
Investing CF	-1,219,000
Is Primary Listing	1
Last Report Date	2025-12-31
Ma150	16.77
Ma150ch	37.72%
Ma20	23.82
Ma20ch	-3.02%
Net CF	-1,147,000
Next Earnings Date	2026-06-15
Open	23.1
Position In Range	42.86
Price Date	2026-05-08
Relative Volume	2.79x
Revenue	10,800,000x
SBC By Revenue	0.92x
Share Based Comp	99,000
Tax By Revenue	-1.02x
Tr6m	84.06%
Volume	9,294
Z Score	3.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SWX/CURN pay a dividend?

Capital-return profile for this ticker.

Performance

SWX/CURN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/CURN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+65.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+71.4%

Negative means the company is buying back shares.

Technical

SWX/CURN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.4

Neutral momentum band

Price vs 200-day MA

+48.4%

50/200-day relationship not available

Beta (5Y)

-0.83

Less volatile than the market

Sharpe ratio

1.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/CURN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/CURN stock rating?

swx/CURN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/CURN analysis?

The full report lives at /stocks/swx/CURN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/CURN?

The latest report frames swx/CURN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/CURN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.